Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Gap junction | R-HSA-190861 | map04540 | 5279552 | None | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | 5279552 | None | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | 5279552 | None | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | 5253409 | None | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | 5253409 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | 5253409 | None | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | dioxybenzone | 33624 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dioxybenzone | 33624 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | dioxybenzone | 33624 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | dioxybenzone | 33624 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | dioxybenzone | 33624 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dioxybenzone | 33624 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | dioxybenzone | 33624 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | dioxybenzone | 33624 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | 5255229 | None | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | 5255229 | None | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | 5255229 | None | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | 5255229 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | 5255229 | None | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | 5255229 | None | drug-path |